In a report released today, Daniel Arias from Stifel Nicolaus maintained a Hold rating on AbSci (ABSI – Research Report), with a price ...

Absci Corp. ( (ABSI) ) has released its Q3 earnings. Here is a breakdown of the information Absci Corp. presented to its investors. Absci ...

Good day and thank you for standing by. Welcome to the Absci Q3 2024 Business Update Conference Call. At this time, all ...

Absci Corporation (ABSI) delivered earnings and revenue surprises of -26.32% and 4.01%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

USA News Group News Commentary – A recent World Economic Forum report highlights AI's potential to ease the strain on healthcare systems worldwide, noting Mayo Clinic’s ...

and NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today reported financial and operating results for the quarter ended ...

Successfully delivered AI de novo designed antibody sequences to AstraZeneca, fulfilling first milestone under collaboration Entered into collaboration with Twist Bioscience to design a novel antibody ...

Guggenheim has recently initiated Absci Corp (ABSI) stock to Buy rating, as announced on October 2, 2024, according to Finviz. Earlier, on July 3, 2024, Morgan Stanley had initiated the stock to ...

Shares of Absci Co. (NASDAQ:ABSI – Get Free Report) have been given a consensus recommendation of “Buy” by the six analysts that are currently covering the firm, Marketbeat reports. Six analysts have ...

and SOUTH SAN FRANCISCO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI) a data-first generative AI drug creation company, and Twist Bioscience Corporation (NASDAQ: TWST) a ...

and SOUTH SAN FRANCISCO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI) a data-first generative AI drug creation company, and Twist Bioscience Corporation (NASDAQ ...